American Infusion Services

Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization. mAbs can protect people from infection, worsening disease, and potential hospitalization. Monoclonal antibody therapy can reduce COVID-19 symptoms, hospitalization or emergency room visits when administered as soon as possible after exposure or within 10 days of symptom onset. 70%-85% reduction in hospitalization and death in patients 80% reduction of infection among patients’ households This is an outpatient treatment, administered either intravenously or through injections. We offer this treatment free for qualifying individuals who have tested positive or been exposed to COVID-19.